Billiontoone (NASDAQ:BLLN) Shares Gap Down – Should You Sell?

Shares of Billiontoone, Inc. (NASDAQ:BLLN) gapped down prior to trading on Tuesday . The stock had previously closed at $105.94, but opened at $98.26. Billiontoone shares last traded at $100.7940, with a volume of 180,266 shares traded.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on BLLN. JPMorgan Chase & Co. increased their price objective on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. BTIG Research dropped their target price on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Wells Fargo & Company decreased their price objective on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Billiontoone in a research note on Friday, May 1st. Six research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $122.43.

Billiontoone Stock Down 7.4%

The company has a market cap of $4.51 billion and a P/E ratio of 471.69. The stock’s 50-day moving average is $79.11. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. Billiontoone’s revenue for the quarter was up 83.8% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.39) EPS. Equities analysts predict that Billiontoone, Inc. will post 0.63 EPS for the current fiscal year.

Institutional Trading of Billiontoone

Institutional investors have recently made changes to their positions in the company. Rossby Financial LCC acquired a new stake in shares of Billiontoone in the fourth quarter valued at about $25,000. Wells Fargo & Company MN purchased a new stake in shares of Billiontoone in the fourth quarter valued at about $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone during the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in Billiontoone during the fourth quarter worth about $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone in the 4th quarter valued at about $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.